MedTrace Logo

Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment

NCT01948570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-09-01

No results posted yet for this study

Summary

Primary end point of the study is the clinical and non-invasive instrumental evaluation of the activity of P-3075 cream on subjects with acne: 20 subjects with a mild/moderate grade and 20 subjects with a moderately severe/severe grade, according to Cunliffe' classification.

Secondary end-points are the cosmetic acceptability and efficacy evaluation by the volunteers and the local tolerability assessed by the investigator and the subjects.

Conditions

Sponsors & Collaborators

  • Derming SRL

    lead OTHER

Principal Investigators

  • Adele Sparavigna, Physician · Derming SRL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01948570 on ClinicalTrials.gov